Small Molecules
1 February 2018
Primary endpoint met in phase II/III clinical study of investigational Parkinson’s disease treatment safinamide in Japan31 January 2018
Artelo Biosciences And The NEOMED Institute Enter Into An Exclusive Global Option And License Agreement31 January 2018
First Wave Bio Inc. to Begin Clinical Trials of Novel Small-Molecule Therapy for Ulcerative Colitis30 January 2018
Otsuka Awarded Grant to Advance Development of Novel Anti-Tuberculosis Compound OPC-167832 with Delamanid30 January 2018
Diffusion Pharmaceuticals Announces First Patient Dosed in Phase 3 Trial with TSC in Inoperable Glioblastoma Multiforme29 January 2018
FDA grants Breakthrough Therapy Designation for Roche’s balovaptan in autism spectrum disorder26 January 2018
GSK announces CHMP positive opinion for labelling update to Relvar Ellipta in patients with asthma26 January 2018
Santhera Receives Negative CHMP Opinion on Appeal for Authorization of Raxone® in Duchenne Muscular Dystrophy25 January 2018
Novan Announces First Patient Dosed in Phase 2 Molluscum Contagiosum Trial with SB20625 January 2018
Takeda and Zinfandel Pharmaceuticals Discontinue TOMMORROW Trial Following Planned Futility Analysis25 January 2018
Ezutromid Significantly Reduced Muscle Damage in DMD Patients in 24-Week Interim Data From Summit’s PhaseOut DMD Clinical Trial24 January 2018
Apexian Pharmaceuticals Opens Phase 1 Clinical Study of APX3330 in Patients with Solid Tumors24 January 2018
IntelGenx Initiates Phase 2A Montelukast Versafilm™ Clinical Trial in Alzheimer’s Patients24 January 2018
BioLineRx Reports Data at ASCO-SITC Conference Showing Complete Tumor Regression by AGI-134 in Pre-Clinical Studies24 January 2018
Amarin’s REDUCE-IT Cardiovascular Outcomes Study Reaches 90% Mark for Reported Primary Events23 January 2018
ChemoCentryx Announces Positive Overall Survival Results with CCR2 Inhibitor CCX872 for Locally Advanced/Metastatic Pancreatic Cancer22 January 2018
SymBio Pharmaceuticals: Initiation of Phase I Clinical Trial for Oral TREAKISYM® in Progressive Solid TumorsNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports